RXO director buys 20,308 shares; moves 49,542 to GRAT
RXO, Inc. — Form 4 insider transaction A company director reported transactions on November 7, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
RXO, Inc. — Form 4 insider transaction
A company director reported transactions on November 7, 2025. The filing shows a purchase of 20,308 shares of common stock at $12.37 per share, held indirectly by a trust. The director also reported transfers coded “G” for no consideration, moving 36,508 shares from the trust and 13,034 shares from direct ownership.
Per the explanation, the director transferred an aggregate of 49,542 shares to a grantor retained annuity trust (GRAT), where the director is trustee and sole beneficiary. Following these transactions, 49,542 shares were listed as indirectly owned by the GRAT.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 20,308 | $12.37 | $251K |
| Gift | Common Stock | 36,508 | $0.00 | $0.00 |
| Gift | Common Stock | 13,034 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. On November 7, 2025, the Reporting Person transferred an aggregate of 49,542 shares of the Issuer's common stock to a grantor retained annuity trust (the "GRAT") for no consideration. The Reporting Person is trustee and the sole beneficiary of the GRAT.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did RXO (RXO) disclose on this Form 4?
What is the director’s post-transaction RXO ownership?
Were any of the RXO transfers made for consideration?
What roles does the director have in the GRAT?
AI-generated analysis. How Rhea-AI works. Not financial advice.